In addition, the low expression of RHBDD2 in supporting cells, specifically fibroblasts, of clinical pancreatic cancer showed a shortened prognosis, and a negative correlation with CXCL12 was observed. The gene discussed is RHBDD2; the disease is familial pancreatic carcinoma.